Tag

biotechnology

• Scribe Therapeutics develops one-time cholesterol treatment without permanent gene editing
  Joseph Morton · Aug 21, 2026
• White House cuts data centers, batteries from critical technology list
  Joseph Morton · Aug 19, 2026
• Definium Therapeutics soars on Phase 3 trial win with LSD depression drug
  Rowan Dunne · Jun 24, 2026
• Canada launches CAD$900 million defence strategy to advance quantum and AI capabilities
  Joseph Morton · Mar 24, 2026
• Allarity Therapeutics doses first patients in VA-funded small cell lung cancer trial
  Rowan Dunne · Feb 25, 2026
• Corvus rally continues as clinical optimism offsets dilution concerns
  Joseph Morton · Jan 23, 2026
• Researchers replicate natural immune signaling to improve cancer immunotherapy
  Joseph Morton · Jan 13, 2026
• Robotic-assisted bronchoscopy aids early diagnosis for lung cancer patients
  Joseph Morton · Dec 17, 2025
• Galleri shows promise in large U.S. based clinical trial
  Joseph Morton · Oct 20, 2025
• Evaxion shares spike as AI-designed melanoma vaccine data hits market
  Joseph Morton · Oct 16, 2025
• Inovio advances DNA medicine for debilitating respiratory condition
  Joseph Morton · Aug 29, 2025
• 180 Life Sciences shares spike 76% on crypto company rebrand
  Joseph Morton · Aug 12, 2025
• Puma Biotechnology shares get favourable price bump on strong Q2 results
  Joseph Morton · Aug 11, 2025
• Y-mAbs stock soars over 100% after acquisition deal with SERB S.A.S.
  Joseph Morton · Aug 6, 2025
• Lantern Pharma completes Japanese enrolment for lung cancer drug trial
  Rowan Dunne · Aug 5, 2025
• Liminatus Pharma shares spike 26% on Digital Asset focused capital raise plans
  Joseph Morton · Jul 25, 2025
• Cizzle Bio submits NIH grant proposal for biomarker blood test for lung cancer
  Joseph Morton · Jul 15, 2025
• Supernus Pharmaceuticals picks up embattled Sage Therapeutics
  Joseph Morton · Jun 16, 2025
• QuidelOrtho seeks FDA approval to complete acquisition of LEX Diagnostics
  Joseph Morton · Jun 6, 2025
• Phase Scientific International advances urine biopsy tech with $34M fundraising round
  Joseph Morton · May 26, 2025
• Breath tests could soon become key diagnosis tool for multiple diseases
  Joseph Morton · May 14, 2025
• Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease
  Joseph Morton · Mar 27, 2025
• Is Cardiff Oncology 15% bump due to positive clinical trials or a short squeeze?
  Joseph Morton · Mar 12, 2025
• TG Therapeutics stock spikes on strong financials and optimism for its flagship drug
  Joseph Morton · Mar 3, 2025
• Sana Biotechnology could offer relief to diabetes type 1 sufferers in the future
  Joseph Morton · Jan 9, 2025
• RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement
  Rowan Dunne · Dec 23, 2024
• Personalis Inc share price jumps 50% on deals with Merck and Moderna
  Joseph Morton · Dec 20, 2024
• Krystal Biotech reports success with inhalable lung cancer drug in early-stage trial
  Rowan Dunne · Dec 19, 2024
• Portage Biotech soars after initiating proceedings for iOx Therapeutics sale
  Rowan Dunne · Dec 17, 2024
• Janux Therapeutics soars on clinical trial data for prostate cancer treatment candidate
  Joseph Morton · Dec 3, 2024
• Breath Diagnostics onboards new president and closes critical financing
  Joseph Morton · Nov 1, 2024
• South Korea's Yuhan has 690% profit spike on U.S. lung cancer drug sales
  Rowan Dunne · Oct 28, 2024
• Bright Minds Bio soars on US$35M private placement; up 5,400% in 5 days
  Rowan Dunne · Oct 18, 2024
• Wave Life Sciences brings big biotech breakthrough with RNA editing therapy
  Joseph Morton · Oct 16, 2024
• Rani Therapeutics enjoys 50% bump on insider buying spree
  Joseph Morton · Oct 15, 2024
• The five front war against cancer: A mugglehead roundup
  Joseph Morton · Oct 12, 2024
• Scholar Rock stock skyrockets on successful phase 3 trial results
  Joseph Morton · Oct 7, 2024
• Capricor Therapeutics gains traction with impending treatment data reveal in Czechia
  Rowan Dunne · Oct 4, 2024
• Onconetix shares go way up on Altos Ventures investment and stock split
  Rowan Dunne · Sep 27, 2024
• Wave Life Sciences shares pop 50% on positive clinical data for common type of muscular dystrophy
  Joseph Morton · Sep 24, 2024
• Prelude Therapeutics Incorporated shares drop 30% on clinical trial news
  Joseph Morton · Sep 13, 2024
• Why are Viridian Therapeutics shares on the rise on Tuesday?
  Joseph Morton · Sep 10, 2024
• Relay Therapeutics shares soar on positive results for breast cancer treatment
  Joseph Morton · Sep 9, 2024
• Breath Diagnostics pioneers novel lung cancer breath test
  Rowan Dunne · Aug 24, 2024
• Kapoose Creek Bio uses AI to identify new fungi-based drugs for brain health
  Rowan Dunne · Jun 4, 2024
• Investors flock to psychedelic start-ups
  Zartasha Mushtaq · Feb 12, 2024
• Compass Pathways, Hackensack Meridian Health collaborate on psilocybin treatment research
  Zartasha Mushtaq · Jan 19, 2024
• LumiraDX expands the commercial expansion of its diabetes test
  Joseph Morton · Nov 14, 2022
• ChitogenX completes opening phases of rotator cuff clinical trial
  Joseph Morton · Nov 9, 2022
• Amyris and the World Wildlife Fund aim to improve ocean health and shark populations
  Joseph Morton · Oct 25, 2022